Pfizer Oncology Medical (@pfizeroncmed) 's Twitter Profile
Pfizer Oncology Medical

@pfizeroncmed

Communicating emerging, trusted scientific Oncology information. Pfizer sponsored, intended only for US healthcare professionals (HCPs). bit.ly/3v2Rs3r

ID: 1306247588409036800

linkhttps://pfizermedical.pfizerpro.com/ calendar_today16-09-2020 15:04:40

1,1K Tweet

33,33K Followers

2 Following

Pfizer Oncology Medical (@pfizeroncmed) 's Twitter Profile Photo

At #WCLC24, see results from a post-hoc analysis of a phase 3 study exploring kinetics of AEs associated with an ALK inhibitor and management practices followed to optimize outcomes for ALK+ advanced NSCLC patients after 5 years of follow up #LungCancer bit.ly/4fpdFvp

At #WCLC24, see results from a post-hoc analysis of a phase 3 study exploring kinetics of AEs associated with an ALK inhibitor and management practices followed to optimize outcomes for ALK+ advanced NSCLC patients after 5 years of follow up #LungCancer bit.ly/4fpdFvp